9-03-2026, 21:18

Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma

Notified -
Globe Newswire9-03-2026, 21:18
30-01-2026, 20:00

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Notified -
Globe Newswire30-01-2026, 20:00
31-03-2025, 15:00

OPEN Health Appoints Matt D’Auria as Chief Executive Officer to Drive Innovation and Growth

Notified -
Globe Newswire31-03-2025, 15:00
16-02-2025, 19:06

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

Notified -
Globe Newswire16-02-2025, 19:06
11-06-2024, 01:33

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
Globe Newswire11-06-2024, 01:33
11-06-2024, 01:33

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

Notified -
Globe Newswire11-06-2024, 01:33
9-04-2024, 13:00

Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma

Notified -
Globe Newswire9-04-2024, 13:00
20-03-2024, 00:58

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
Globe Newswire20-03-2024, 00:58
16-03-2023, 01:08

Hyloris reports full year results for 2022 & provides

Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing
Globe Newswire16-03-2023, 01:08